Global Market Study on Hemoglobinopathy

Oct 2016| PMR065A| Persistence Market Research

Report Highlights

This report by Persistence Market Research examines the global hemoglobinopathy market for the period 2016–2024. The primary objective of the report is to offer updates and information related to market opportunities in the global hemoglobinopathy market. The global hemoglobinopathy market report begins with an exhaustive executive summary giving the report data overview and the market taxonomy or segments covered in the report. It is followed by an overview of market dynamics of the global hemoglobinopathy market, which includes an in-depth analysis of key trends, drivers, restraints, and opportunities, and reimbursement scenario influencing the growth of the global hemoglobinopathy market. Impact analysis of key growth drivers and restraints based on a weighted average model have been included in the report after detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the global hemoglobinopathy market.

Based on indication type, the market has been segmented into Sickle Cell Disease, Beta Thalassemia, and Alpha Thalassemia. A detailed analysis has been provided for these segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and BPS analysis. Based on test type, the market has been segmented into red blood cell (RBC) count test, genetic testing, hemoglobin by high performance liquid chromatography (HPLC) test,  hemoglobin isoelectric (Hb IEF) focusing, hemoglobin electrophoresis (Hb ELP) test, and hemoglobin solubility test. The next section of the report analyzes the global hemoglobinopathy market by region and provides a comprehensive market outlook for 2016–2024. The report also analyzes the impact of drivers and restraints in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). These sections evaluate the present scenario and future growth prospects of the global hemoglobinopathy market during the period 2016–2024. We have considered 2015 as the base year and provided data for the forecast period, i.e., 2016–2024.

In the final section of the report on the global hemoglobinopathy market, a competitive landscape is included to provide report audiences with a dashboard view based on categories of providers in the global hemoglobinopathy market product portfolio and key differentiators. Key categories of providers covered in the report are hemoglobinopathy diagnosis devices, ready-to-use kits, and reagents manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the global hemoglobinopathy market value chain. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and successes in the global hemoglobinopathy market. Detailed profiles of providers are also included in the scope of the report to evaluate their long- and short-term strategies, key offerings, SWOT analysis, and recent developments in the global hemoglobinopathy market. Key competitors covered in terms of manufacturers include Abbott Diagnostics, Bio-Rad Laboratories Inc., Danaher Corporation, Mindray Medical International Ltd., Nexcelom Bioscience LLC., Nihon Kohden Corporation, PerkinElmer Inc., Siemens Healthineers, and Sysmex Corporation.

Research methodology

To ascertain the global hemoglobinopathy market size, we have considered revenue generated by device manufacturers. The forecast presented here assesses the total revenue by value across the global hemoglobinopathy market. In order to offer an accurate forecast, we started by sizing up the current market, which forms the basis of how the global hemoglobinopathy market is expected to develop in the future. Given the characteristics of the market, we have triangulated the outcome of three different types of analyses based on supply side, downstream industry demand, and the economic envelope. In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyze it based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the global hemoglobinopathy market.

The different segments of the global hemoglobinopathy market are analyzed in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identifying various key trends in the global hemoglobinopathy market. Another important feature of this report is the analysis of key segments in terms of absolute dollar opportunity, critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective in the global hemoglobinopathy market. To understand key growth segments in terms of growth and adoption for hemoglobinopathy diagnosis globally, Persistence Market Research has developed the global hemoglobinopathy market attractiveness index to help providers identify real market opportunities.

  • Table 1 : Global Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2024
  • Table 2 : Global Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2024
  • Table 3 : Global Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Test Type, 2015�2024
  • Table 4 : Global Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Region, 2015�2024
  • Table 5 : North America Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 6 : North America Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2024
  • Table 7 : North America Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2024
  • Table 8 : North America Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Test Type, 2015�2024
  • Table 9 : Latin America Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 10 : Latin America Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2024
  • Table 11 : Latin America Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2024
  • Table 12 : Latin America Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Test Type, 2015�2024
  • Table 13 : Europe Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 14 : Europe Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2024
  • Table 15 : Europe Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2024
  • Table 16 : Europe Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Test Type, 2015�2024
  • Table 17 : Asia Pacific Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 18 : Asia Pacific Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2024
  • Table 19 : Asia Pacific Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2024
  • Table 20 : Asia Pacific Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Test Type, 2015�2024
  • Table 21 : Middle East & Africa Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Country, 2015�2024
  • Table 22 : Middle East & Africa Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By End User, 2015�2024
  • Table 23 : Middle East & Africa Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Indication, 2015�2024
  • Table 24 : Middle East & Africa Hemoglobinopathy Market Value (US$ Mn) Analysis and Forecast By Test Type, 2015�2024
  • Figure 1 : Routine Red Blood Cell (RBC) Count Test Pricing Difference (US$) By Region, 2015 A
  • Figure 2 : Genetic Testing Pricing Difference (US$) By Region, 2015 A
  • Figure 3 : Hemoglobin by high performance liquid chromatography (HPLC) Test Pricing Difference (US$) By Region, 2015 A
  • Figure 4 : Hemoglobin isoelectric focusing (Hb IEF) Pricing Difference (US$) By Region, 2015 A
  • Figure 5 : Hemoglobin electrophoresis (Hb ELP) Test Pricing Difference (US$) By Region, 2015 A
  • Figure 6 : Hemoglobin solubility test (SST) Pricing Difference (US$) By Region, 2015 A
  • Figure 7 : Global Hemoglobinopathy Market Value (US$ Mn) Forecast, 2016-2024
  • Figure 8 : Global Hemoglobinopathy Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 9 : Global Hemoglobinopathy Market Share and BPS Analysis (%) By Indication, 2016 & 2024
  • Figure 10 : Global Hemoglobinopathy Y-o-Y growth (%) By Indication, 2016-2024
  • Figure 11 : Global Hemoglobinopathy Absolute $ Opportunity (US$ Mn) By Sickle Cell Disease Segment, 2015�2024
  • Figure 12 : Global Hemoglobinopathy Absolute $ Opportunity (US$ Mn) By Beta Thalassemia Segment, 2015�2024
  • Figure 13 : Global Hemoglobinopathy Absolute $ Opportunity (US$ Mn) By Alpha Thalassemia Segment, 2015�2024
  • Figure 14 : Global Hemoglobinopathy Market Attractiveness Analysis By Indication, 2016-2024
  • Figure 15 : Global Hemoglobinopathy Market Share and BPS Analysis (%) By End User, 2016 & 2024
  • Figure 16 : Global Hemoglobinopathy Y-o-Y growth (%) By End User, 2016-2024
  • Figure 17 : Global Hemoglobinopathy Market Absolute $ Opportunity By Hospitals Segment, 2016-2024
  • Figure 18 : Global Hemoglobinopathy Market Absolute $ Opportunity By Diagnostics Laboratories Segment, 2016-2024
  • Figure 19 : Global Hemoglobinopathy Market Absolute $ Opportunity By Clinics Segment, 2016-2024
  • Figure 20 : Global Hemoglobinopathy Market Attractiveness Analysis By End-user, 2016-2024
  • Figure 21 : Hemoglobinopathy Market Share Analysis (%) By Test Type, 2016 & 2024
  • Figure 22 : Global Hemoglobinopathy Y-o-Y growth (%) By Test Type, 2016-2024
  • Figure 23 : Global Hemoglobinopathy Absolute $ Opportunity (US$ Mn) By RBC Count, 2015�2024
  • Figure 24 : Global Hemoglobinopathy Absolute $ Opportunity (US$ Mn) By Genetic Testing, 2015�2024
  • Figure 25 : Global Hemoglobinopathy Absolute $ Opportunity (US$ Mn) By Hemoglobin HPLC, 2015�2024
  • Figure 26 : Global Hemoglobinopathy Absolute $ Opportunity (US$ Mn) By Hemoglobin Isoelectric Focusing, 2015�2024
  • Figure 27 : Global Hemoglobinopathy Absolute $ Opportunity (US$ Mn) By Hemoglobin Electrophoresis, 2015�2024
  • Figure 28 : Global Hemoglobinopathy Absolute $ Opportunity (US$ Mn) By Hemoglobin Solubility Test, 2015�2024
  • Figure 29 : Global Hemoglobinopathy Market Attractiveness Analysis By End User, 2016-2024
  • Figure 30 : Global Hemoglobinopathy Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024
  • Figure 31 : Global Hemoglobinopathy Market Share Analysis (%) By Region, 2016 & 2024
  • Figure 32 : Global Hemoglobinopathy Y-o-Y growth (%) By Region, 2016-2024
  • Figure 33 : North America Hemoglobinopathy Market Absolute $ Opportunity, 2016-2024
  • Figure 34 : Latin America Hemoglobinopathy Market Absolute $ Opportunity, 2016-2024
  • Figure 35 : Europe Hemoglobinopathy Market Absolute $ Opportunity, 2016-2024
  • Figure 36 : APAC Hemoglobinopathy Market Absolute $ Opportunity, 2016-2024
  • Figure 37 : MEA Hemoglobinopathy Market Absolute $ Opportunity, 2016-2024
  • Figure 38 : Global Hemoglobinopathy Market Attractiveness Analysis By Region, 2016-2024
  • Figure 39 : North America Hemoglobinopathy Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 40 : North America Hemoglobinopathy Y-o-Y growth (%) By Country, 2016-2024
  • Figure 41 : North America Hemoglobinopathy Market Attractiveness Analysis By Indication, 2016-2024
  • Figure 42 : North America Hemoglobinopathy Market Attractiveness Analysis By End User, 2016-2024
  • Figure 43 : North America Hemoglobinopathy Market Attractiveness Analysis By Test Type, 2016-2024
  • Figure 44 : Latin America Hemoglobinopathy Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 45 : Latin America Hemoglobinopathy Y-o-Y growth (%) By Country, 2016-2024
  • Figure 46 : Latin America Hemoglobinopathy Market Attractiveness Analysis By Indication, 2016-2024
  • Figure 47 : Latin America Hemoglobinopathy Market Attractiveness Analysis By End User, 2016-2024
  • Figure 48 : Latin America Hemoglobinopathy Market Attractiveness Analysis By Test Type, 2016-2024
  • Figure 49 : Europe Hemoglobinopathy Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 50 : Europe Hemoglobinopathy Y-o-Y growth (%) By Country, 2016-2024
  • Figure 51 : Europe Hemoglobinopathy Market Attractiveness Analysis By Indication, 2016-2024
  • Figure 52 : Europe Hemoglobinopathy Market Attractiveness Analysis By End User, 2016-2024
  • Figure 53 : Europe Hemoglobinopathy Market Attractiveness Analysis By Test Type, 2016-2024
  • Figure 54 : Asia Pacific Hemoglobinopathy Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 55 : Asia Pacific Hemoglobinopathy Y-o-Y growth (%) By Country, 2016-2024
  • Figure 56 : Asia Pacific Hemoglobinopathy Market Attractiveness Analysis By Indication, 2016-2024
  • Figure 57 : Asia Pacific Hemoglobinopathy Market Attractiveness Analysis By End User, 2016-2024
  • Figure 58 : Asia Pacific Hemoglobinopathy Market Attractiveness Analysis By Test Type, 2016-2024
  • Figure 59 : Middle East & Africa Hemoglobinopathy Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 60 : Middle East & Africa Hemoglobinopathy Y-o-Y growth (%) By Country, 2016-2024
  • Figure 61 : Middle East & Africa Hemoglobinopathy Market Attractiveness Analysis By Indication, 2016-2024
  • Figure 62 : Middle East & Africa Hemoglobinopathy Market Attractiveness Analysis By End User, 2016-2024
  • Figure 63 : Middle East & Africa Hemoglobinopathy Market Attractiveness Analysis By Test Type, 2016-2024

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report